The decision to use recombinant human granulocyte colony-stimulating factor (rhG-CSF; Neupogen, Amgen, Thousand Oaks, California) alone or with chemotherapy for mobilization of PBPC was based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback